NavaDerm Announces Chief Executive Officer Roy Geronemus, M.D., becomes CEO of NavaDerm Renowned dermatologist with 37 years of experience to drive platform growth
News provided by
Share this article
Share this article
NEW YORK, March 16, 2021 /PRNewswire/ NavaDerm Partners, LLC ( NavaDerm or the Company ), a dermatology platform and portfolio company of BelHealth Investment Partners, LLC ( BelHealth ), announced the appointment of Dr. Roy Geronemus as Chief Executive Officer ( CEO ).
Board-certified dermatologist, Roy G. Geronemus, M.D., graduated from Harvard University and pursued his medical education at the University of Miami School of Medicine where he is a member of the school s Alumni Hall of Fame. He trained in dermatology at the New York University Medical Center where he was the chief resident and subsequently underwent a fellowship training in Mohs Micrographic Surgery and Cutaneous Oncology. He founded the Laser & Skin Surgery Center of New York (LSSC